PPCB — Propanc Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.04m
- $1.23m
Annual cashflow statement for Propanc Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.74 | -2.03 | -2.66 | -2.66 | -1.82 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.68 | 0.44 | 1.05 | 1.08 | 0.468 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.209 | 0.443 | 0.167 | 0.473 | 0.417 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -1.85 | -1.15 | -1.44 | -1.11 | -0.935 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | -0.151 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.89 | 1.06 | 1.49 | 1.11 | 0.942 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.065 | -0.065 | 0.002 | 0.006 | 0.011 |